APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 188 filers reported holding APELLIS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.45 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $259,623 | -58.8% | 6,825 | -1.4% | 0.01% | -57.1% |
| Q2 2023 | $630,321 | +30.2% | 6,919 | -5.7% | 0.02% | +5.0% |
| Q1 2023 | $484,212 | +28.9% | 7,341 | +1.1% | 0.02% | +11.1% |
| Q4 2022 | $375,518 | -99.9% | 7,262 | -0.5% | 0.02% | -28.0% |
| Q3 2022 | $498,385,000 | +150925.8% | 7,297 | 0.0% | 0.02% | +66.7% |
| Q2 2022 | $330,000 | -28.4% | 7,297 | -19.5% | 0.02% | -16.7% |
| Q1 2022 | $461,000 | +53.7% | 9,069 | +43.2% | 0.02% | +80.0% |
| Q4 2021 | $300,000 | -47.5% | 6,335 | -29.9% | 0.01% | -50.0% |
| Q2 2021 | $571,000 | +68.9% | 9,041 | +14.7% | 0.02% | +42.9% |
| Q1 2021 | $338,000 | – | 7,881 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 2,503,059 | $170,959,000 | 29.50% |
| ACUTA CAPITAL PARTNERS, LLC | 554,000 | $37,838,000 | 16.29% |
| Avoro Capital Advisors LLC | 10,125,000 | $691,538,000 | 12.78% |
| Sio Capital Management, LLC | 507,700 | $34,676,000 | 11.02% |
| Logos Global Management LP | 1,300,000 | $88,790,000 | 10.92% |
| EcoR1 Capital, LLC | 5,183,431 | $354,028,000 | 10.45% |
| Cormorant Asset Management, LP | 1,478,000 | $100,947,000 | 7.06% |
| Finepoint Capital LP | 266,090 | $18,174,000 | 5.98% |
| Ghost Tree Capital, LLC | 275,000 | $18,783,000 | 5.27% |
| Boxer Capital, LLC | 1,303,700 | $89,043,000 | 5.01% |